NKX2-1 Gene Chorea Hereditary Benign Genetic Test
Test Name: NKX2-1 Gene Chorea Hereditary Benign Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for NKX2-1 Gene Chorea, hereditary benign NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NKX2-1 Gene Chorea, hereditary benign.
Test Details
The NKX2-1 gene is responsible for producing a protein that plays a crucial role in the development of the brain, lungs, and thyroid gland. Mutations in this gene have been linked to a rare condition known as NKX2-1 gene chorea, hereditary benign.
This condition is characterized by involuntary movements of the limbs, face, and tongue, which can range from mild to severe. It typically begins in childhood or early adulthood and is inherited in an autosomal dominant pattern, meaning that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition.
NGS (next-generation sequencing) genetic testing can be used to identify mutations in the NKX2-1 gene. This test involves sequencing the entire gene to identify any changes or variations that may be responsible for the development of the condition.
Genetic testing can be useful for individuals who have a family history of NKX2-1 gene chorea, hereditary benign, as well as those who are experiencing symptoms of the condition. It can also be used to confirm a diagnosis and provide information about the risk of passing the condition on to future generations.
It is important to note that genetic testing is not always necessary or appropriate for everyone, and individuals should discuss their options with a healthcare professional before undergoing any testing.
| Test Name | NKX2-1 Gene Chorea hereditary benign Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for NKX2-1 Gene Chorea, hereditary benign NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NKX2-1 Gene Chorea, hereditary benign |
| Test Details | The NKX2-1 gene is responsible for producing a protein that plays a crucial role in the development of the brain, lungs, and thyroid gland. Mutations in this gene have been linked to a rare condition known as NKX2-1 gene chorea, hereditary benign. This condition is characterized by involuntary movements of the limbs, face, and tongue, which can range from mild to severe. It typically begins in childhood or early adulthood and is inherited in an autosomal dominant pattern, meaning that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the NKX2-1 gene. This test involves sequencing the entire gene to identify any changes or variations that may be responsible for the development of the condition. Genetic testing can be useful for individuals who have a family history of NKX2-1 gene chorea, hereditary benign, as well as those who are experiencing symptoms of the condition. It can also be used to confirm a diagnosis and provide information about the risk of passing the condition on to future generations. It is important to note that genetic testing is not always necessary or appropriate for everyone, and individuals should discuss their options with a healthcare professional before undergoing any testing. |
